Use a product that includes Macitentano or its salt in combination with a rented preparation or a myth inhibitor to prepare a useful drug for the treatment of malignant blood sugar.

• 收藏
• 分享

专利权人:

ACTELION PHARMACEUTICALS LTD

发明人:

REGENASS URS

申请号：

CL2013002193

公开号：

CL2013002193A1

申请日:

2013.07.31

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The invention relates to the use of macitentan in combination with radiotherapy or with both radiotherapy and a cytotoxic therapy agent (such as temozolomide or paclitaxel) in the treatment of malignant glioma, in particular glioblastoma multiforme.USO DE UN PRODUCTO QUE COMPRENDE MACITENTANO O UNA SAL DEL MISMO EN COMBINACION CON UN AGENTE ALQUILANTE O UN INHIBIDOR MITOTICO PARA PREPARAR UN MEDICAMENTO UTIL EN EL TRATAMIENTO DE GLIOMA MALIGNO.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/